8-KEarnings & ResultsExhibits & Filings

Guardant Health, Inc. 8-K Report, Financial Results (Nov 19, 2018)

Filed November 19, 2018For Securities:GH

Summary

Guardant Health, Inc. (GH) filed an 8-K on November 19, 2018, primarily to furnish a press release announcing its financial results for the third quarter ended September 30, 2018. While the filing itself is brief and contains no new operational details, the incorporated press release provides investors with key performance indicators and financial outcomes for the period. Investors should refer to the furnished press release (Exhibit 99.1) for specific financial data and management commentary regarding revenue, expenses, and profitability. This report marks a routine disclosure of quarterly financial performance. The significance for investors lies in scrutinizing the growth trajectory, revenue generation from its blood-based cancer detection tests, and any commentary on future outlook or strategic developments that may have been included in the press release. It's important to note that the information furnished in this 8-K is not considered 'filed' for purposes of Section 18 of the Exchange Act, meaning it doesn't carry the same liability as a formally filed document, but it remains a key source of current financial information for shareholders and potential investors.

Key Highlights

  • 1Guardant Health released its Q3 2018 financial results via a press release on November 19, 2018.
  • 2The 8-K filing primarily serves to incorporate the Q3 2018 earnings press release by reference.
  • 3Investors must consult Exhibit 99.1 (the press release) for detailed financial and operational results for the quarter ended September 30, 2018.
  • 4This filing is a standard disclosure of quarterly financial performance.
  • 5The information furnished is not deemed 'filed' under Section 18 of the Exchange Act, but remains crucial for performance monitoring.
  • 6Key metrics such as revenue, test volumes, and any forward-looking statements are expected to be within the press release.

Frequently Asked Questions

The main purpose of this 8-K filing is to officially report Guardant Health's financial results for the third quarter ended September 30, 2018, by incorporating its press release (Exhibit 99.1) into the filing.

Detailed financial results, including revenue, expenses, and other key performance indicators for the quarter ended September 30, 2018, can be found in the press release furnished as Exhibit 99.1 to this 8-K filing.

This 8-K filing itself does not contain new operational or strategic information. It primarily serves as a vehicle to present the Q3 2018 financial results released by the company. Any additional commentary or strategic insights would be contained within the referenced press release (Exhibit 99.1).

When information is furnished and not 'filed' under Section 18, it generally means the company is providing the information for transparency but is not subject to the same level of liability for misstatements or omissions in that specific furnished content under that particular section of the law. However, investors should still consider it a primary source for understanding the company's performance.